OrbiMed Israel BioFund GP Limited Partnership - Jun 18, 2025 SCHEDULE 13D/A Report for Chemomab Therapeutics Ltd. Ordinary Shares, no par value. American Depository Shares, each of which represents twenty Ordinary Shares, no par value (CMMB)

Filing Manager
OrbiMed Israel BioFund GP Limited Partnership
Reporting Manager
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP
Security
Chemomab Therapeutics Ltd. Ordinary Shares, no par value. American Depository Shares, each of which represents twenty Ordinary Shares, no par value
Symbol
CMMB
Shares outstanding
20.2M shares
Disclosed Ownership
970K shares
Ownership
4.8%
Form type
SCHEDULE 13D/A
Date filed
6/23/2025, 05:06 PM
Date of event
Jun 18, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP 4.8% 970K 0 970K /s/ Carl L. Gordon Carl L. Gordon/Director 0001569821
ORBIMED ISRAEL GP LTD. 4.8% 970K 0 970K /s/ Carl L. Gordon Carl L. Gordon/Director 0001569590
CHIMOVITS EREZ 4.8% 970K 0 970K /s/ Erez Chimovits Erez Chimovits 0001706399
GORDON CARL L 4.8% 970K 0 970K /s/ Carl L. Gordon Carl L. Gordon 0001282930